Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 71 - 80 of 1824 shown below

  • Kaibara, N

    H Andachi, K Yashima, M Koda, K Kawaguchi, A Kitamura, A Hosoda, Y Kishimoto, G Shiota, H Ito, M Makino, N Kaibara, H Kawasaki and Y Murawaki

    Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma

    doi:10.1038/sj.bjc.6600501

  • M Ikeguchi and N Kaibara

    survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma

    doi:10.1038/sj.bjc.6600546

  • H Saito, S Tsujitani, S Oka, A Kondo, M Ikeguchi, M Maeta and N Kaibara

    The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma

    doi:10.1038/sj.bjc.6690719

  • Kaibuchi, K

    S Miyamoto, H Baba, S Kuroda, K Kaibuchi, T Fukuda, Y Maehara and T Saito

    Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer

    doi:10.1054/bjoc.2000.1386

  • Kaijen, P

    A Claeskens, N Ongenae, J M Neefs, P Cheyns, P Kaijen, M Cools and E Kutoh

    Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation

    doi:10.1054/bjoc.1999.1051

  • Kaijser, M

    M Kaijser, O Akre, S Cnattingius and A Ekbom

    Preterm birth, birth weight, and subsequent risk of female breast cancer

    doi:10.1038/sj.bjc.6601357

  • Kailash, U

    U Kailash, C C Soundararajan, R Lakshmy, R Arora, S Vivekanandhan and B C Das

    Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer

    advance online publication, 2006-10-24 00:00:00.000;

    doi:10.1038/sj.bjc.6603375

  • Kaina, B

    R Becker, A Ritter, U Eichhorn, J Lips, B Bertram, M Wiessler, M Z Zdzienicka and B Kaina

    Induction of DNA breaks and apoptosis in crosslink-hypersensitive V79 cells by the cytostatic drug beta-D-glucosyl-ifosfamide mustard

    doi:10.1038/sj.bjc.6600027

  • G Fritz, C Brachetti, F Bahlmann, M Schmidt and B Kaina

    Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters

    doi:10.1038/sj.bjc.6600510

  • S C Naumann, W P Roos, E Jöst, C Belohlavek, V Lennerz, C W Schmidt, M Christmann and B Kaina

    Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53

    advance online publication, 2009-01-06 00:00:00.000;

    doi:10.1038/sj.bjc.6604856

  • H Seker, B Bertram, A Bürkle, B Kaina, J Pohl, H Koepsell and M Wies zligler

    Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent

    doi:10.1054/bjoc.1999.0974

  • Kainu, T

    K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna and R Winqvist

    Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

    doi:10.1054/bjoc.2000.1530

  • Kainulainen, T

    S Hamidi, T Salo, T Kainulainen, J Epstein, K Lerner and H Larjava

    Expression of alphavbeta6integrin in oral leukoplakia

    doi:10.1054/bjoc.1999.1130

  • Kainz, C

    M Boogaerts, B Coiffier and C Kainz

    Impact of epoetin beta on quality of life in patients with malignant disease

    doi:10.1038/sj.bjc.6600801

  • L Hefler, C Tempfer, G Heinze, K Mayerhofer, G Breitenecker, S Leodolter, A Reinthaller and C Kainz

    Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients

    doi:10.1038/sj.bjc.6690776

  • G H Windbichler, H Hausmaninger, W Stummvoll, A H Graf, C Kainz, J Lahodny, U Denison, E Müller-Holzner and C Marth

    Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

    doi:10.1054/bjoc.1999.1053

  • Kaira, K

    K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, S Tanaka, T Ishizuka, Y Kanai, H Endou, T Nakajima and M Mori

    Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

    advance online publication, 2008-02-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604235